Stryker commenced launch of Synchfix EVT, its next-generation flexible syndesmotic fixation device designed to simplify surgical deployment while supporting ankle stabilization in patients with syndesmotic disruptions.
Synchfix EVT features an all-in-one system that integrates suture tensioning handles within the implant instrumentation, along with a handle design for one-handed surgical implant deployment. The device is engineered to provide a seamless user experience with an ergonomic handle and a low-profile titanium medial implant.
Synchfix EVT is intended for soft tissue and bone fixation for ankle syndesmosis disruptions with or without ankle fractures and as an adjunct in connection with hardware for ankle fractures such as Weber B, Weber C and Maisonneuve in adult and adolescent patient populations. Notably, it is the first ankle syndesmotic flexible fixation device on the market indicated for use in adolescents, expanding treatment options for younger patients.
“Stryker is dedicated to helping foot and ankle surgeons treat their patients more efficiently while enhancing patient care and the overall healthcare experience,” said Adam Jacobs, VP and GM of Stryker’s Foot & Ankle business. “Synchfix EVT reflects our commitment to delivering next-generation solutions in soft tissue by designing technologies that help surgeons work more efficiently while keeping patient care and safety at the center.”
Stryker commenced launch of Synchfix EVT, its next-generation flexible syndesmotic fixation device designed to simplify surgical deployment while supporting ankle stabilization in patients with syndesmotic disruptions.
Synchfix EVT features an all-in-one system that integrates suture tensioning handles within the implant instrumentation, along...
Stryker commenced launch of Synchfix EVT, its next-generation flexible syndesmotic fixation device designed to simplify surgical deployment while supporting ankle stabilization in patients with syndesmotic disruptions.
Synchfix EVT features an all-in-one system that integrates suture tensioning handles within the implant instrumentation, along with a handle design for one-handed surgical implant deployment. The device is engineered to provide a seamless user experience with an ergonomic handle and a low-profile titanium medial implant.
Synchfix EVT is intended for soft tissue and bone fixation for ankle syndesmosis disruptions with or without ankle fractures and as an adjunct in connection with hardware for ankle fractures such as Weber B, Weber C and Maisonneuve in adult and adolescent patient populations. Notably, it is the first ankle syndesmotic flexible fixation device on the market indicated for use in adolescents, expanding treatment options for younger patients.
“Stryker is dedicated to helping foot and ankle surgeons treat their patients more efficiently while enhancing patient care and the overall healthcare experience,” said Adam Jacobs, VP and GM of Stryker’s Foot & Ankle business. “Synchfix EVT reflects our commitment to delivering next-generation solutions in soft tissue by designing technologies that help surgeons work more efficiently while keeping patient care and safety at the center.”
Copy to clipboard 
